Spider Rock Advisors, LLC Johnson & Johnson Put Options Transaction History

Spider Rock Advisors, LLC

$6.17 Billion
Q3 2024

Put Options

16 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 01, 2024	BUY	$145.48 - $167.38 $814,688 - $937,328	5,600 Added 28.14%	25,500 $4.13 Million
Q2 2024 Aug 12, 2024	SELL	$144.38 - $157.78 $1.31 Million - $1.44 Million	-9,100 Reduced 31.38%	19,900 $2.91 Million
Q1 2024 Apr 30, 2024	SELL	$155.22 - $162.74 $3.03 Million - $3.17 Million	-19,500 Reduced 40.21%	29,000 $4.59 Million
Q4 2023 Jan 30, 2024	BUY	$145.6 - $158.88 $6.58 Million - $7.18 Million	45,200 Added 1369.7%	48,500 $6.5 Million
Q3 2021 Oct 19, 2021	SELL	$161.5 - $179.47 $355,300 - $394,834	-2,200 Reduced 40.0%	3,300 $461,000
Q2 2021 Aug 13, 2021	BUY	$159.48 - $171.07 $494,387 - $530,317	3,100 Added 129.17%	5,500 $747,000
Q1 2021 May 12, 2021	SELL	$153.07 - $170.48 $61,228 - $68,192	-400 Reduced 14.29%	2,400 $313,000
Q4 2020 Jan 28, 2021	SELL	$137.11 - $157.38 $150,821 - $173,118	-1,100 Reduced 28.21%	2,800 $349,000
Q2 2020 Aug 13, 2020	SELL	$128.81 - $155.51 $502,359 - $606,489	-3,900 Reduced 50.0%	3,900 $11,000
Q1 2020 May 11, 2020	BUY	$111.14 - $153.99 $255,622 - $354,177	2,300 Added 41.82%	7,800 $56,000
Q3 2019 Oct 28, 2019	BUY	$126.95 - $142.14 $279,290 - $312,707	2,200 Added 66.67%	5,500 $11,000
Q2 2019 Jul 29, 2019	BUY	$131.15 - $144.24 $131,150 - $144,240	1,000 Added 43.48%	3,300 $5,000
Q1 2019 May 15, 2019	BUY	$125.72 - $139.79 $150,864 - $167,748	1,200 Added 109.09%	2,300 $5,000
Q4 2018 Feb 08, 2019	BUY	$122.84 - $147.84 $135,124 - $162,624	1,100 New	1,100 $8,000
Q3 2018 Nov 08, 2018	SELL	$121.58 - $142.88 $133,738 - $157,168	-1,100 Closed	0 $0
Q2 2018 Aug 08, 2018	BUY	$119.4 - $131.76 $131,340 - $144,936	1,100 New	1,100 $4,000

Others Institutions Holding JNJ

# of Institutions

4,239

Shares Held

1.7B

Call Options Held

12.5M

Put Options Held

10.3M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $406B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Spider Rock Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Spider Rock Advisors, LLC with notifications on news.

Account